MedTrace Logo

Development and Feasibility Testing of an Advanced Practice Physiotherapy Role in Chronic Pain Management

NCT05336903 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2025-03-20

No results posted yet for this study

Summary

The current study is intended to evaluate the feasibility of conducting a future trial to evaluate the effects of implementing an advanced practice physiotherapist (APP) role within a chronic pain clinic setting.

Conditions

Interventions

BEHAVIORAL

APP-led model of care for chronic pain management

The APP will provide an assessment using a biopsychosocial approach. The assessment will include: * taking a comprehensive history * screening for pathologies contributing to the participant's chronic pain * a physical assessment * screening for comorbid health conditions, using the appropriate screening tools, that require specific care (e.g., depression, addiction, post-traumatic stress) * identifying psychosocial risk factors associated with pain and disability * evaluating pain severity and interference The APP will make recommendations to the participant and the chronic pain clinic health care team based on findings from the comprehensive assessment. These recommendations include, but are not limited to, the need for urgent or emergent referrals, medication management, referral and integration of other health care providers, the need for interventional procedures, or group-based treatment options.

Sponsors & Collaborators

  • University Hospitals Kingston Foundation - Women's Giving Circle

    collaborator UNKNOWN

  • Jordan Miller, PT, PhD

    lead OTHER

Principal Investigators

  • Jordan Miller, PhD · Queen's University

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-24
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05336903 on ClinicalTrials.gov